PACLITAXEL GELATIN NANOPARTICLES FOR INTRAVESICAL BLADDER CANCER THERAPY

PURPOSE: We have shown that inadequate drug delivery to tumor cells is a major cause of failures in intravesical therapy of nonmuscle-invading bladder cancer. This is partly due to the dilution of drug concentration by urine production during treatment. To address this problem, we developed gelatin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lu, Ze, Yeh, Teng-Kuang, Wang, Jie, Chen, Ling, Lyness, Greg, Xin, Yan, Wientjes, M. Guillaume, Bergdall, Valerie, Couto, Guillermo, Alvarez-Berger, Francisco, Kosarek, Carrie E., Au, Jessie L-S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3655418/
https://ncbi.nlm.nih.gov/pubmed/21334664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.11.091
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados